Anti-TNF and IBD: bibliography

被引：0
|
作者：
Roblin, X. [1 ]
机构：
[1] Ctr Hosp Albert Michallon, Hospitalisat A, Dept Hepatogastroenterol, F-38043 Grenoble, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2008年 / 32卷 / 05期
关键词：
D O I：
10.1016/j.gcb.2008.03.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：482 / 485
页数：4
相关论文
共 50 条
  • [41] Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
    Rafael Denadai
    Fábio V. Teixeira
    Rogério Saad-Hossne
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 744 - 744
  • [42] Immunogenicity of Anti-TNF in IBD Patients Aged Over 60 Years
    Paul, Stephane
    Rinaldi, Leslie
    Williet, Nicolas
    Del Tedesco, Emilie
    Jarlot, Camille
    Genin, Christian
    Phelip, Jean Marc
    Depince, Anne
    Roblin, Xavier
    GASTROENTEROLOGY, 2016, 150 (04) : S410 - S410
  • [43] ANTI-TNF THERAPY IN ELDERLY PEOPLE IN IBD: AN ITALIAN MULTICENTRE SURVEY
    Cottone, M.
    Kohn, A.
    Daperno, M.
    Armuzzi, A.
    Guidi, L.
    D'Inca, R.
    Bossa, F.
    Biancone, L.
    Gionchetti, P.
    Ardizzone, S.
    Papi, C.
    Fries, W.
    Danese, S.
    Cappello, M.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S128 - S128
  • [44] Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD?
    Lakatos, P. L.
    Miheller, P.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 179 - 186
  • [45] Switching out of class or to another anti-TNF agent is the most effective strategy in IBD patients with immunogenicity against anti-TNF antibodies
    Anjie, S.
    Hanzel, J.
    Gecse, K. B.
    D'Haens, G. R.
    Brandse, J. F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 803 - 803
  • [46] Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications
    Winter, Rachel W.
    Friedman, Sonia
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 132 - 133
  • [47] Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)
    Visuri, I.
    Eriksson, C.
    Mardberg, E.
    Grip, O.
    Gustavsson, A.
    Hjortswang, H.
    Karling, P.
    Montgomery, S.
    Myrelid, P.
    Olen, O.
    Ludvigsson, J. F.
    Halfvarson, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S443 - S444
  • [48] Vedolizumab-induced endoscopic remission in anti-TNF exposed and anti-TNF naive IBD patients: a large single-centre experience
    Verstockt, B.
    Mertens, E.
    Outtier, A.
    Van Assche, G.
    Vermeire, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S47 - S48
  • [49] Outcomes in IBD Patients Who Are Exposed to a Subsequent Anti-TNF Agent Following Anti-TNF Drug Induced Lupus-Like Reaction
    Venu, Mukund
    Dodda, Amar
    Gonzaga, Jason E.
    Naik, Amar S.
    Venu, Nanda
    Perera, Lilani P.
    Stein, Daniel
    GASTROENTEROLOGY, 2013, 144 (05) : S409 - S409
  • [50] HRQOL Measures In IBD Patients Receiving Prolonged Treatment with Anti-TNF Therapy
    Yoon, Sonia
    DeCross, Arthur
    Shah, Ashok
    St Hilaire, Lydia
    Sherman, Michael
    Saubermann, Lawrence
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S455 - S456
12345